Akebia Therapeutics Inc (STU:AX9)
€ 3.382 +0.13 (+3.93%) Market Cap: 897.21 Mil Enterprise Value: 846.75 Mil PE Ratio: 0 PB Ratio: 41.91 GF Score: 49/100

Akebia Therapeutics Inc (STU:AX9) Transcripts

  • 1